首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Assembly and Functional Analysis of an S/MAR Based Episome with the Cystic Fibrosis Transmembrane Conductance Regulator Gene
【2h】

Assembly and Functional Analysis of an S/MAR Based Episome with the Cystic Fibrosis Transmembrane Conductance Regulator Gene

机译:囊性纤维化跨膜电导调节基因的基于S / MAR的附加体的组装和功能分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Improving the efficacy of gene therapy vectors is still an important goal toward the development of safe and efficient gene therapy treatments. S/MAR (scaffold/matrix attached region)-based vectors are maintained extra-chromosomally in numerous cell types, which is similar to viral-based vectors. Additionally, when established as an episome, they show a very high mitotic stability. In the present study we tested the idea that addition of an S/MAR element to a CFTR (cystic fibrosis transmembrane conductance regulator) expression vector, may allow the establishment of a CFTR episome in bronchial epithelial cells. Starting from the observation that the S/MAR vector pEPI-EGFP (enhanced green fluorescence protein) is maintained as an episome in human bronchial epithelial cells, we assembled the CFTR vector pBQ-S/MAR. This vector, transfected in bronchial epithelial cells with mutated CFTR, supported long term wt CFTR expression and activity, which in turn positively impacted on the assembly of tight junctions in polarized epithelial cells. Additionally, the recovery of intact pBQ-S/MAR, but not the parental vector lacking the S/MAR element, from transfected cells after extensive proliferation, strongly suggested that pBQ-S/MAR was established as an episome. These results add a new element, the S/MAR, that can be considered to improve the persistence and safety of gene therapy vectors for cystic fibrosis pulmonary disease.
机译:改善基因治疗载体的功效仍然是开发安全有效的基因治疗方法的重要目标。在多种细胞类型中,基于S / MAR(支架/基质附着区域)的载体在染色体外得以维持,这与基于病毒的载体相似。另外,当建立为附加体时,它们显示出非常高的有丝分裂稳定性。在本研究中,我们测试了在CFTR(囊性纤维化跨膜电导调节剂)表达载体中添加S / MAR元素可能允许在支气管上皮细胞中建立CFTR附加体的想法。从观察到S / MAR载体pEPI-EGFP(增强的绿色荧光蛋白)在人支气管上皮细胞中作为附加体维持,我们组装了CFTR载体pBQ-S / MAR。该载体在CFTR突变的支气管上皮细胞中转染,支持长期wt CFTR表达和活性,进而积极影响极化上皮细胞紧密连接的组装。另外,在广泛增殖后,从转染的细胞中恢复完整的pBQ-S / MAR,但不缺少缺少S / MAR元件的亲本载体,强烈表明pBQ-S / MAR被确立为附加体。这些结果增加了一个新的要素,即S / MAR,可以认为该要素可改善用于囊性纤维化肺病的基因治疗载体的持久性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号